Cases 41 - 50 of 2,371
Azurity Pharmaceuticals, Inc. et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01080
Plaintiff:
Azurity Pharmaceuticals, Inc., Arbor Pharmaceuticals, LLC and Takeda Pharmaceutical Company Limited
Defendant:
Teva Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd.
Cause Of Action: 35 U.S.C. § 1 Patent Infringement
WILLIAMS v. ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. et al
as 1:2023cv20392
Plaintiff:
RICHARD WILLIAMS
Defendant:
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD, HUAHAI U.S. INC., SOLCO HEALTHCARE U.S., LLC and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
Celgene Corporation et al v. Teva Pharmaceuticals, Inc.
as 1:2023cv01008
Plaintiff:
Celgene Corporation, Celgene International Sarl and Bristol-Myers Squibb Company
Defendant:
Teva Pharmaceuticals, Inc.
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
HURST v. TEVA PHARMACEUTICAL INDUSTRIES LTD. et al
as 1:2023cv20308
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Plaintiff:
CHRISTOPHER J. HURST
Defendant:
TEVA PHARMACEUTICAL INDUSTRIES LTD., ACETERIS, LCC, ACTAVIS PHARMA, INC. and others
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
MANTALIS v. AUROBINDO PHARM, LTD. et al
as 1:2023cv14463
Plaintiff:
STELIOS MANTALIS
Defendant:
AUROBINDO PHARM, LTD., HETERO DRUGS LTD., HETERO LABS LTD. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
CASTELLO v. JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC et al
as 2:2023cv07341
Plaintiff:
KATHLEEN CASTELLO
Defendant:
JANSSEN PHARMACEUTICALS, INC f/k/a JANSSEN PHARMACEUTICA INC. f/k/a ORTHO-MCNEIL-JANSSEN PHARMACEUTICALS, INC, JANSSEN ORTHO LLC, JANSSEN RESEARCH & DEVELOPMENT LLC f/k/a JOHNSON AND JOHNSON PHARMACEUTICAL RESEARCH AND DEVELOPMENT LLC and others
In Re:
ELMIRON (PENTOSAN POLYSULFATE SODIUM) PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
THERAVANCE BIOPHARMA R&D IP, LLC et al v. EUGIA PHARMA SPECIALITIES LTD. et al
as 1:2023cv06667
Plaintiff:
THERAVANCE BIOPHARMA R&D IP, LLC, THERAVANCE BIOPHARMA US, INC., THERAVANCE BIOPHARMA IRELAND LIMITED and others
Defendant:
EUGIA PHARMA SPECIALITIES LTD., EUGIA US LLC, AUROBINDO PHARMA USA, INC. and others
Counter Claimant:
LUPIN INC.
Cause Of Action: 15 U.S.C. § 1126 Patent Infringement
SHANNON et al v. AUROBINDO PHARMA, LTD. et al
as 1:2023cv04229
Plaintiff:
STANLEY SHANNON and NELLIE F. LAWLER-SHANNON
Defendant:
AUROBINDO PHARMA, LTD., MYLAN LABORATORIES, LTD., MYLAN N.V. and others
In Re:
VALSARTAN LOSARTAN AND IRBESARTAN PRODUCTS LIABILITY LITIGATION
Cause Of Action: 28 U.S.C. § 1332 Diversity-Product Liability
In re: Abbott Laboratories, et al
as 23-2412
Petitioner:
In re: ABBOTT LABORATORIES, ABBVIE INC, ABBVIE PRODUCTS LLC and others
Respondent:
KING DRUG CO OF FLORENCE INC, AMERISOURCEBERGEN CORP, AMERISOURCEBERGEN DRUG CORP and others
OWSINSKI v. AMPHASTAR PHARMACEUTICALS, INC
as 2:2023cv01340
Plaintiff:
KRISTIN I. OWSINSKI
Defendant:
AMPHASTAR PHARMACEUTICALS, INC, MYLAN INC, MYLAN LABORATORIES LIMITED and others
Cause Of Action: 28 U.S.C. § 1441 Notice of Removal-Personal Injury
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
